Skip to main content
Equibles

CANADA LIFE ASSURANCE Co

Insurance

Position in TGTX — Tg Therapeutics, Inc.

CIK 1046192 WINNIPEG, A2
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,857,428
+$2,068,256 QoQ
Shares Held
106,615
-6.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 426 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CANADA LIFE ASSURANCE Co holds $335,351,557 across 80 Biotechnology names. TGTX ranks #17 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 182,365 $90,586,166
2 REGN
Regeneron Pharmaceuticals, Inc.
 86,761 $54,098,953
3 ALNY
Alnylam Pharmaceuticals, Inc.
 69,102 $20,801,775
4 INCY
Incyte Corp
 126,229 $14,309,319
5 ARGX
Argenx SE
 14,868 $13,794,084
6 MRNA
Moderna, Inc.
 152,228 $10,660,526
7 RPRX
Royalty Pharma plc
 185,316 $10,390,668
8 EXEL
Exelixis, Inc.
 155,922 $8,483,716

All Filings in TGTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,857,428 106,615
2026-03-31 $3,789,172 114,063
2025-12-31 $3,575,262 119,935
2025-09-30 $4,778,759 132,284
2025-06-30 $4,206,799 116,888
2025-03-31 $4,625,572 117,311
2024-12-31 $3,871,973 128,637
2024-09-30 $3,096,087 132,368
2024-06-30 $257,492 14,474
2024-03-31 $189,683 12,471
2023-12-31 $213,004 12,471
2023-09-30 $104,257 12,471
2023-06-30 $138,383 5,571
2023-03-31 $100,497 6,682
2022-12-31 $79,048 6,682
2022-09-30 $39,557 6,682
2022-06-30 $28,398 6,682
2022-03-31 $63,545 6,682
2021-12-31 $126,958 6,682
2021-09-30 $222,376 6,682
2021-06-30 $259,194 6,682
2021-03-31 $319,951 6,638
2020-12-31 $381,774 7,339
2020-09-30 $196,391 7,339
2020-06-30 $103,166 5,296
2020-03-31 $53,037 5,390